Indocyanine green clearance test combined with meld score in predicting the short-term prognosis of patients with acute liver failure

Hepatobiliary and Pancreatic Diseases International

Volumn 13, Issue 3, 2014, Pages 271-275

  Feng, Hong Ling ^a   Li, Qian ^a   Wang, Lin ^a   Yuan, Gui Yu ^a   Cao, Wu Kui ^a  

^a Tianjin Second People s Hospital   (China)

Author keywords

Acute liver failure; Indocyanine green clearance test; Model for end stage liver disease; Prognosis

Indexed keywords

BILIRUBIN; CREATININE; INDOCYANINE GREEN; BIOLOGICAL MARKER; COLORING AGENT;

ACUTE LIVER FAILURE; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HUMAN; INDOCYANINE GREEN CLEARANCE TEST; INTERNATIONAL NORMALIZED RATIO; KING COLLEGE HOSPITAL CRITERIA; LIVER CLEARANCE; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; PLASMAPHERESIS; PREDICTIVE VALUE; PROGNOSIS; PROTHROMBIN TIME; PULSE SPECTROPHOTOMETRY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY; SURVIVOR; AREA UNDER THE CURVE; BLOOD; CHI SQUARE DISTRIBUTION; LIVER; LIVER FAILURE, ACUTE; LIVER FUNCTION TEST; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; TIME FACTOR;

ADULT; AGE FACTORS; AREA UNDER CURVE; BILIRUBIN; BIOMARKERS; CHI-SQUARE DISTRIBUTION; COLORING AGENTS; CREATININE; FEMALE; HUMANS; INDOCYANINE GREEN; INTERNATIONAL NORMALIZED RATIO; LIVER; LIVER FAILURE, ACUTE; LIVER FUNCTION TESTS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTHROMBIN TIME; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SEVERITY OF ILLNESS INDEX; SPECTROPHOTOMETRY; TIME FACTORS;

EID: 84904042590     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-3872(14)60040-0     Document Type: Article

References (25)

1. Wojcicki M, Lubikowski J, Wrzesinski M, Post M, Jarosz K, Hydzik P, et al. Outcome of emergency liver transplantation including mortality on the waiting list: a single-center experience. Transplant Proc 2007;39:2781-2784.
2. Wei G, Bergquist A, Broomé U, Lindgren S, Wallerstedt S, Almer S, et al. Acute liver failure in Sweden: etiology and outcome. J Intern Med 2007;262:393-401.
3. Liou IW, Larson AM. Role of liver transplantation in acute liver failure. Semin Liver Dis 2008;28:201-209.
4. Taylor RM, Tujios S, Jinjuvadia K, Davern T, Shaikh OS, Han S, et al. Short and long-term outcomes in patients with acute liver failure due to ischemic hepatitis. Dig Dis Sci 2012;57: 777-785.
5. Katoonizadeh A, Decaestecker J, Wilmer A, Aerts R, Verslype C, Vansteenbergen W, et al. MELD score to predict outcome in adult patients with non-acetaminophen-induced acute liver failure. Liver Int 2007;27:329-334.
6. Dhiman RK, Jain S, Maheshwari U, Bhalla A, Sharma N, Ahluwalia J, et al. Early indicators of prognosis in fulminant hepatic failure: an assessment of the Model for End-Stage Liver Disease (MELD) and King's College Hospital criteria. Liver Transpl 2007;13:814-821.
7. Simpson KJ, Bates CM, Henderson NC, Wigmore SJ, Garden OJ, Lee A, et al. The utilization of liver transplantation in the management of acute liver failure: comparison between acetaminophen and non-acetaminophen etiologies. Liver Transpl 2009;15:600-609.
8. Du WB, Pan XP, Li LJ. Prognostic models for acute liver failure. Hepatobiliary Pancreat Dis Int 2010;9:122-128.
9. Polson J. Assessment of prognosis in acute liver failure. Semin Liver Dis 2008;28:218-225.
10. Wheeler HO, Cranston WI, Meltzer JI. Hepatic uptake and biliary excretion of indocyanine green in the dog. Proc Soc Exp Biol Med 1958;99:11-14.
11. Haruna M, Kumon K, Yahagi N, Watanabe Y, Ishida Y, Kobayashi N, et al. Blood volume measurement at the bedside using ICG pulse spectrophotometry. Anesthesiology 1998;89: 1322-1328.
12. Nishioka M, Ishikawa M, Hanaki N, Kashiwagi Y, Miki H, Miyake H, et al. Perioperative hemodynamic study of patients undergoing abdominal surgery using pulse dye densitometry. Hepatogastroenterology 2006;53:874-878.
13. Du ZG, Li B, Wei YG, Yin J, Feng X, Chen X. A new scoring system for assessment of liver function after successful hepatectomy in patients with hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2011;10:265-269.
14. Sheng QS, Lang R, He Q, Yang YJ, Zhao DF, Chen DZ. Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis. Hepatobiliary Pancreat Dis Int 2009;8:46-49.
15. Cheung TT, Chan SC, Chok KS, Chan AC, Yu WC, Poon RT, et al. Rapid measurement of indocyanine green retention by pulse spectrophotometry: a validation study in 70 patients with Child-Pugh A cirrhosis before hepatectomy for hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2012;11:267-271.
16. Li H, Li B, Wei Y. Potential factors dedicated to postoperative liver dysfunction in patients with normal preoperative ICG-15 clearance rate. Dig Dis Sci 2013;58:1163-1164.
17. Lee WM, Larson AM, Stravitz RT. AASLD Position Paper; The management of acute liver failure: update 2011. Hepatology 2011;1-22.
18. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33: 464-470.
19. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97:439-445.
20. O'Grady JG. Broadening the view of acetaminophen hepatotoxicity. Hepatology 2005;42:1252-1254.
21. Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Diseases and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Diagnostic and treatment guidelines for liver failure. Zhonghua Gan Zang Bing Za Zhi 2006;14:643-646.
22. Yantorno SE, Kremers WK, Ruf AE, Trentadue JJ, Podestá LG, Villamil FG. MELD is superior to King's college and Clichy's criteria to assess prognosis in fulminant hepatic failure. Liver Transpl 2007;13:822-828.
23. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31:864-871.
24. Freeman RB Jr, Wiesner RH, Harper A, McDiarmid SV, Lake J, Edwards E, et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 2002;8:851-858.
25. Merle U, Sieg O, Stremmel W, Encke J, Eisenbach C. Sensitivity and specificity of plasma disappearance rate of indocyanine green as a prognostic indicator in acute liver failure. BMC Gastroenterol 2009;9:91.